AJTMH ASTMH Job Mart
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Am. J. Trop. Med. Hyg., 79(3), 2008, pp. 435-437
Copyright © 2008 by The American Society of Tropical Medicine and Hygiene

This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Web of Science (2)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Alborzi, A.
Right arrow Articles by Kadivar, M. R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Alborzi, A.
Right arrow Articles by Kadivar, M. R.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH
Hazardous Substances DB
*AMPHOTERICIN B
Medline Plus Health Information
*Leishmaniasis
Related Collections
Right arrow Leishmaniasis

CASE REPORT


Isolation of Leishmania tropica from a Patient with Visceral Leishmaniasis and Disseminated Cutaneous Leishmaniasis, Southern Iran

Abdolvahab Alborzi*, Gholam R. Pouladfar, Mahdi Fakhar, Mohammad H. Motazedian, Gholam R. Hatam, AND Mohammad R. Kadivar
Professor Alborzi Clinical Microbiology Research Center, and Department of Medical Parasitology and Mycology, Shiraz University of Medical Sciences, Shiraz, Iran; Department of Medical Parasitology and Mycology, Mazandaran University of Medical Sciences, Sari, Iran

 

ABSTRACT

We report a case visceral leishmaniasis with disseminated cutaneous leishmaniasis caused by Leishmania tropica in southern Iran. Typing of this parasite was performed by a species-specific polymerase chain reaction and isoenzyme electrophoresis.

 

INTRODUCTION

Disseminated cutaneous leishmaniasis (DCL) is characterized by 10–800 lesions on the head, limbs, and trunk. Most lesions are small, papular, and appear simultaneously with or secondarily to one or several ulcerated lesions of localized cutaneous leishmaniasis.1 This disease has been reported in a small subset of immunocompetent patients infected with Leishmania braziliensis and L. amazonensis in Brazil.2 A case of DCL caused by L. guyanensis was reported from French Guiana.1 We report a patient with DCL accompanied by visceral leishmaniasis (VL) caused by L. tropica.

 

CASE REPORT

In September 2006, a 15-year-old woman was admitted to Nemazee Hospital in Shiraz, Iran. In October 2005, a papular lesion appeared on her left forearm that progressed within one month to a painless ulcerative lesion. Leishmania amastigotes were seen in a skin biopsy specimen. She was treated with meglumine antimoniate and showed some improvement. Nine months later, numerous, small, papulonodular, painless, non-pruritic, pink lesions appeared on her extremities, back, and face, a few of which became ulcerative (Figure 1Go), and the primary lesion worsened (Figure 2Go). A raised superficial lesion was detected on the nasal aspect of a left sclera biopsy specimen (Figure 3Go). The liver and spleen were palpated 6 cm and 12 cm below costal margins, respectively. Abundant Leishmania amastigotes were found in lesions of her skin and left sclera. Because of treatment failure, she was referred to us and hospitalized.


Figure 1
View larger version (83K):
[in this window]
[in a new window]

 
    FIGURE 1. Multiple papulonodular lesions with a few ulcers on lower extremities of the patient. The site where a skin biopsy specimen was obtained from the left leg is shown. This figure appears in color at www.ajtmh.org.

 

Figure 2
View larger version (103K):
[in this window]
[in a new window]

 
    FIGURE 2. Non-tender ulcerative lesion approximately 3 x 4 cm with an elevated border and a dry necrotic center on the dorsal surface of the left forearm of the patient. This figure appears in color at www.ajtmh.org.

 

Figure 3
View larger version (114K):
[in this window]
[in a new window]

 
    FIGURE 3. Raised superficial lesion on the nasal aspect of left sclera of a biopsy specimen of the patient. This figure appears in color at www.ajtmh.org.

 
The patient was treated at 1.5 years of age for a disseminated infection with bacille Calmette-Guérin for two years and showed a good response. Results of immunologic analysis for serum immunoglobulins, a nitroblue-tetrazolium test, a complement CH50 test, and flow cytometery of leukocytes were inconclusive. No other pertinent findings were detected in her past history and family history.

The result of an indirect immunofluorescent antibody test for VL was positive with a titer of 1:1,024. A leishmanin skin test (LST) result was positive. Kinetoplast DNA of L. tropica was detected by a specific polymerase chain reaction on whole blood, bone marrow, and skin biopsy specimens. Results were compared with those of reference strains L. infantum (MCAN/IR/96/LON-49) and L. tropica (MHOM/IR/89/ARD-2). Parasites isolated from cultures of skin biopsy specimens and characterized by isoenzyme analysis with five enzymatic systems (glucose-6-phosphate isomerase, phospho- glucomutase, nucleoside hydrolase, malate dehydrogenase, and glucose-6-phosphate dehydrogenase) and polyacrylamide gel electrophoresis were identified as L. tropica.3

The patient had a hemoglobin level of 8.8 g/dL, a serum total protein level of 10.7 g/dL, and a globulin level of 8 g/dL. Despite positive PCR results, Leishmania amastigotes were not seen in bone marrow aspirates and biopsy specimens. Abdominal ultrasonography showed hepatosplenomegaly and multiple intra-abdominal lymph nodes. The patient was negative for human immunodeficiency virus.

The patient did not respond to treatment with amphotericin B (1 mg/kg/day for 45 days) and a four-month course of meglumine antimoniate and interferon-{gamma} Therefore, a 28-day course of miltefosine was given. At the end of therapy, the skin lesions were flattened and disappeared after a four-month follow-up. The size of liver and spleen decreased significantly.

 

DISCUSSION

On the basis of multiple lesions, ulceration at the onset of disease, and positive LST results, the patient was diagnosed as a case of DCL. As in our patient, many reported cases of DCL had Leishmania amastigotes in skin lesions.2,4

In differential diagnosis, we considered two other forms of leishmaniasis in which a large number of skin lesions occur: diffuse cutaneous leishmaniasis and post–kala-azar dermal leishmaniasis. In diffuse cutaneous leishmaniasis, parasite-laden nodules do not ulcerate and the T cell response to Leishmania antigen is poor.5 Post–kala-azar dermal leishmaniasis, which is common in Sudan and India and has been reported from Iran, is characterized by macular, maculopapular, and nodular skin lesions and usually starts periorally in patients who have recovered from VL.6,7 Therefore, the skin lesions in our patient were characteristic of DCL accompanied by VL. Five cases of VL with DCL have been previously reported in southern Iran for which the cause has not been identified.8

The fact the patient had a positive LST result is unusual for a case of VL. The positive skin test result in our patient after recurrence may be caused by memory T cells generated during the first episode of the infection when the single skin lesion was detected. These T cells may participate in the cellular response in the skin test after the second episode of infection.

Leishmania tropica, which is typically more dermatotropic, is one of the most common causes of localized cutaneous leishmaniasis along the Mediterranean basin and in Iran. However, this parasite been confirmed as the cause of VL in Iran and viscerotropic leishmaniasis among U.S. servicemen in Persian Gulf Conflict.911

The diagnosis of leishmaniasis associated with immunodeficiency cannot be rejected because we could not evaluate interferon-{gamma} defects. There was no history of recurrent infection in our patient and immunologic abnormalities in her family but results of immunologic studies were inconclusive. To our knowledge, this is the first case of DCL accompanied by VL caused by L. tropica to be reported from southern Iran.


Received January 17, 2008. Accepted for publication April 1, 2008.

Acknowledgment: We thank H. Khajehei for editing the manuscript.

* Address correspondence to Abdolvahab Alborzi, Alborzi Clinical Microbiology Research Center, Shiraz University of Medical Sciences, Shiraz, Iran. E-mail: alborziiraj2004{at}yahoo.com Back

Authors’ addresses: Abdolvahab Alborzi, Gholam R. Pouladfar, and Mohammad R. Kadivar, Professor Alborzi Clinical Microbiology Research Center, Shiraz University of Medical Sciences, Shiraz, Iran, Tel: 98-711-6470205, Fax: 98-711-6287071, E-mail: alborziiraj2004{at}yahoo.com. Mahdi Fakhar, Department of Medical Parasitology and Mycology, Mazandaran University of Medical Sciences, Sari, Iran. Mohammad H. Motazedian and Gholam R. Hatam, Department of Medical Parasitology and Mycology, Shiraz University of Medical Sciences, Shiraz, Iran.

 

REFERENCES

  1. Couppie P, Clyti E, Sainte-Marie D, Dedet JP, Carme B, Pradinaud R, 2004. Disseminated cutaneous leishmaniasis due to Leishmania guyanensis: case of a patient with 425 lesions. Am J Trop Med Hyg 71: 558–560.[Abstract/Free Full Text]
  2. Carvalho EM, Barral A, Costa JM, Bittencourt A, Marsden P, 1994. Clinical and immunopathological aspects of disseminated cutaneous leishmaniasis. Acta Trop 56: 315–325.[Web of Science][Medline]
  3. Hatam GR, Hosseini SM, Ardehali S, 1999. Isoenzyme studies in characterization of Leishmania isolated in Iran. Iran J Med Sci 24: 8–13.
  4. Bonfante-Garrido R, Barroeta S, de Alejos MA, Melendez E, Torrealba J, Valdivia O, Momen H, Grimaldi G Jr, 1996. Disseminated American cutaneous leishmaniasis. Int J Dermatol 35: 561–565.[Web of Science][Medline]
  5. Convit J, Pinardi ME, Rondon AJ, 1972. Diffuse cutaneous leishmaniasis: a disease due to an immunological defect of the host. Trans R Soc Trop Med Hyg 66: 603–610.[Web of Science][Medline]
  6. Alborzi A, Ahanchin AR, Karimi A, 2002. Recurrent post-kala-azar dermal leishmaniasis. Eur J Pediat Dermatol 12: 97–100.
  7. Baghestanian S, Sodeifi M, Kumar PV, 1998. Post-Kala-azar dermal leishmaniasis. Eur J Pediat Dermatol 8: 277–279.
  8. Kumar PV, Sadeghi E, Torabi S, 1989. Kala azar with disseminated dermal leishmaniasis. Am J Trop Med Hyg 40: 150–155.[Abstract/Free Full Text]
  9. Motazedian H, Noamanpoor B, Ardehali S, 2002. Characterization of Leishmania parasites isolated from provinces of the Islamic Republic of Iran. East Mediterr Health J 8: 338–344.[Medline]
  10. Alborzi A, Rasouli M, Shamsizadeh A, 2006. Leishmania tropica-isolated patient with visceral leishmaniasis in southern Iran. Am J Trop Med Hyg 74: 306–307.[Abstract/Free Full Text]
  11. Magill AJ, Grogl M, Gasser RA, Sun W, Oster CN, 1993. Visceral infection caused by Leishmania tropica in veterans of Operation Desert Storm. N Engl J Med 328: 1383–1387.[Abstract/Free Full Text]




This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Web of Science (2)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Alborzi, A.
Right arrow Articles by Kadivar, M. R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Alborzi, A.
Right arrow Articles by Kadivar, M. R.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH
Hazardous Substances DB
*AMPHOTERICIN B
Medline Plus Health Information
*Leishmaniasis
Related Collections
Right arrow Leishmaniasis


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS